Live Evaluations
Real World Approaches to Actinic Keratosis Management
About
Real World Approaches to Actinic Keratosis Management
This activity is supported by an educational grant from Almirall and SUN Pharmaceuticals.
Learning Objectives
At the completion of this activity, participants should be better able to:
Define the various therapies available for the management of actinic keratosis
Describe expert recommended approaches for integrating combination AK therapies into practice
Identify approaches for delivering optimal patient-tailored AK therapeutic care
Intended Audience
Faculty
Aaron Farberg, MD
Bare Dermatology
Baylor Scott & White Health System
Dallas, TX
Todd Schlesinger, MD
Director, Dermatology and Laser Center of Charleston
Clinical Research Center of the Carolinas
Charleston, SC
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
Speakers’ Bureau or Honoraria: Novartis, Sanofi Regeneron, SUN Pharma, Galderma, Castle Biosciences, Janssen, Ortho Dermatologics, Pfizer
No relevant financial relationships with any Ineligible Company in the past 24 months.
The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.